Latest News about AZN
Recent news which mentions AZN
From Benzinga
3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
November 21, 2024
From Motley Fool
This AstraZeneca Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
November 20, 2024
From Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
From Benzinga
From Benzinga
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
November 15, 2024
From Benzinga
From Benzinga
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
November 14, 2024
Tickers
AZN
From Motley Fool
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
November 13, 2024
From Benzinga
AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript
November 12, 2024
Tickers
AZN
From Motley Fool
AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investigations 'Very Seriously'
November 12, 2024
From Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
From Benzinga
The Week Kamala Harris Lost (Nov 4-8), These Large Cap Stocks Lost Big
November 11, 2024
From Benzinga
From Benzinga
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
November 08, 2024
From Benzinga
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
November 05, 2024
From Benzinga
Why Is AstraZeneca Stock Sinking On Tuesday?
November 05, 2024
From Benzinga
From Benzinga
3 Magnificent Stocks Under $100 to Buy in November
November 03, 2024
From Motley Fool
3 Rock-Solid Dividend Stocks You Can Buy and Hold Forever
October 31, 2024
From Motley Fool
Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast
October 25, 2024
From Benzinga
Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder
October 24, 2024
From Benzinga
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
October 23, 2024
From Benzinga
GSK Settles Majority Of Zantac Lawsuits, But Pipeline Doubts Remain
October 11, 2024
From Benzinga
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
October 09, 2024
From Benzinga
From Motley Fool
Dow Tumbles Over 400 Points; Duckhorn Portfolio Shares Surge
October 07, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.